Gastroenterology
Volume 128, Issue 7 , Pages 2124-2130 , June 2005

Molecular Analysis to Detect Pancreatic Ductal Adenocarcinoma in High-Risk Groups

  • Li Yan

      Affiliations

    • Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom
    • ,
  • Christopher McFaul

      Affiliations

    • Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom
    • ,
  • Nathan Howes

      Affiliations

    • Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom
    • ,
  • Jane Leslie

      Affiliations

    • Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom
    • ,
  • Gillian Lancaster

      Affiliations

    • Centre for Medical Statistics and Health Evaluation, University of Liverpool, Liverpool, United Kingdom
    • ,
  • Theresa Wong

      Affiliations

    • Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom
    • ,
  • Jane Threadgold

      Affiliations

    • Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom
    • ,
  • Jonathan Evans

      Affiliations

    • Department of Radiology, Royal Liverpool University Hospital, Liverpool, United Kingdom
    • ,
  • Ian Gilmore

      Affiliations

    • Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, England
    • ,
  • Howard Smart

      Affiliations

    • Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, England
    • ,
  • Martin Lombard

      Affiliations

    • Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, England
    • ,
  • John Neoptolemos

      Affiliations

    • Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom
    • ,
  • William Greenhalf

      Affiliations

    • Division of Surgery and Oncology, University of Liverpool, Liverpool, United Kingdom
    • Corresponding Author InformationAddress requests for reprints to: William Greenhalf, PhD, Division of Surgery and Oncology, University of Liverpool, UCD Building, 5th Floor, Daulby Street, Liverpool, L69 3GA, England; fax: (0151) 706-5826.

Received 7 September 2004 ,Accepted 17 February 2005.

References 

  1. Ariyama J , Suyama M , Satoh K , Sai J . Imaging of small pancreatic ductal adenocarcinoma . Pancreas . 1998;16:396–401
  2. Wong T, Howes N, Threadgold J, Smart HL, Lombard MG, Sutton R, et al. Molecular diagnosis of early pancreatic ductal adenocarcinoma in high risk patients . Pancreatology . 2001;1:486–509
  3. Rulyak SJ , Brentnall TA . Inherited pancreatic cancer (surveillance and treatment strategies for affected families) . Pancreatology . 2001;1:477–485
  4. Brentnall TA , Bronner MP , Byrd DR , Haggitt RC , Kimmey MB . Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer . Ann Intern Med . 1999;131:247–255
  5. Rosch T, Schusdziarra V, Born P, Bautz W, Baumgartner M, Ulm K, et al. Modern imaging methods versus clinical assessment in the evaluation of hospital in-patients with suspected pancreatic disease . Am J Gastroenterol . 2000;95:2261–2270
  6. Kondoh S , Kaino M , Okita S , Ryozawa S , Akiyama T , Okita K . Detection of Ki-ras and p53 gene mutations in tissue and pancreatic juice from pancreatic adenocarcinomas . J Gastroenterol . 1998;33:390–396
  7. Yamashita K , Kida Y , Shinoda H , Kida M , Okayasu I . K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination . Jpn J Cancer Res . 1999;90:240–248
  8. Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma . Cancer Res . 1993;53:2472–2474
  9. Watanabe H, Yamaguchi Y, Ha A, Hu YX, Motoo Y, Okai T, et al. Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay . Pancreas . 1998;17:341–347
  10. Kondo H, Sugano K, Fukayama N, Kyogoku A, Nose H, Shimada K, et al. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma . Cancer . 1994;73:1589–1594
  11. Trumper L, Menges M, Daus H, Kohler D, Reinhard JO, Sackmann M, et al. Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile (a multicenter prospective trial) . J Clin Oncol . 2002;20:4331–4337
  12. Furuya N , Kawa S , Akamatsu T , Furihata K . Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice . Gastroenterology . 1997;113:593–598
  13. Van Laethem JL, Bourgeois V, Parma J, Delhaye M, Cochaux P, Velu T, et al. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases . Gastrointest Endosc . 1998;47:479–485
  14. Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease . Gastroenterology . 1996;110:227–231
  15. Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation . Cancer Res . 1993;53:953–956
  16. Fukushima N, Walter KM, Uek T, Sato N, Matsubayashi H, Cameron JL, et al. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice . Cancer Biol Ther . 2003;2:78–83
  17. Matsubayashi H, Sato N, Fukushima N, Yeo CJ, Walter KM, Brune K, et al. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues . Clin Cancer Res . 2003;9:1446–1452
  18. Klump B, Hsieh CJ, Nehls O, Dette S, Holzmann K, Kiesslich R, et al. Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions . Br J Cancer . 2003;88:217–222
  19. Yamaguchi Y, Watanabe H, Yrdiran S, Ohtsubo K, Motoo Y, Okai T, et al. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer (comparison with K-ras mutation) . Clin Cancer Res . 1999;5:1147–1153
  20. Wang Y , Yamaguchi Y , Watanabe H , Ohtsubo K , Motoo Y , Sawabu N . Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas . Pancreas . 2004;28:13–19
  21. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, et al  A simple p53 functional assay for screening cell lines, blood, and tumors . Proc Natl Acad Sci U S A . 1995;92:3963–3967
  22. Olivier M , Eeles R , Hollstein M , Khan MA , Harris CC , Hainaut P . The IARC TP53 database (new online mutation analysis and recommendations to users) . Hum Mutat . 2002;19:607–614
  23. Waridel F , Estreicher A , Bron LRI . Field cancerisation and polyclonal p53 mutations in the upper aero-digestive tract . Oncogene . 1997;14:163–169
  24. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers . Cancer Res . 1995;55:4525–4530
  25. Lo YM , Wong IH , Zhang J , Tein MS , Ng MH , Hjelm NM . Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction . Cancer Res . 1999;59:3899–3903
  26. Greenberg R , Daniels S , Flanders W , Eley J , Boring J . Medical epidemiology . London, UK: McGraw-Hill; 2001;
  27. Altman D , Machin D , Bryant T , Gardner M . In: Statistics with confidence . 2nd ed.. London, UK: BMJ Books; 2000;
  28. Gietz RD , Schiestl RH . Applications of high efficiency lithium acetate transformation of intact yeast cells using single-stranded nucleic acids as carrier . Yeast . 1991;7:253–263
  29. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, et al. Database of p53 gene somatic mutations in human tumors and cell lines . Nucleic Acids Res . 1994;22:3551–3555
  30. Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe . Clin Gastroenterol Hepatol . 2004;2:252–261
  31. Ulrich CD . Pancreatic cancer in hereditary pancreatitis (consensus guidelines for prevention, screening and treatment) . Pancreatology . 2001;1:416–422
  32. Clayton SJ, Scott FM, Walker J, Callaghan K, Haque K, Liloglou T, et al. K-ras point mutation detection in lung cancer (comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification) . Clin Chem . 2000;46:1929–1938
  33. Howes N , Greenhalf W , Neoptolemos J . Screening for early pancreatic ductal adenocarcinoma in hereditary pancreatitis . Med Clin North Am . 2000;84:719–738
  34. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests . JAMA . 1999;282:1061–1066

 Supported by the European Union (Framework 5), North West Cancer Research Fund, UK; North West Region Biomed, UK; Frances and Augustus Newman Foundation, UK; Royal Liverpool University Hospital R&D, UK; and Solvay Healthcare, Hanover, Germany.

PII: S0016-5085(05)00387-2

doi: 10.1053/j.gastro.2005.03.006

Gastroenterology
Volume 128, Issue 7 , Pages 2124-2130 , June 2005

Article Tools

* Image Usage & Resolution